Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus and the related disease. The latest patent landscape report published
Two Montreal lawyers have applied to register the term “COVID-19” as a trademark, a bid that experts say is unlikely to succeed. Meriem Amir and Giovanni De Sua filed applications on March 25 to
COVID-19 vaccines and other coronavirus-related medical tools for the duration of the pandemic. The proposal aimed to address an urgent problem: multinational pharmaceutical companies and their backers
patents related to COVID-19 vaccines. Acuitas told the court on Monday that CureVac omitted its scientists from patent applications for lipid nanoparticle technology used in messenger RNA-based vaccines
New progress in scientific research brings the new hopes for life. On August 11, the National Intellectual Property Administration issued a patent authorization notice to the applicants, the Military ...
New progress in scientific research brings the new hopes for life. On August 11, the National Intellectual Property Administration issued a patent authorization notice to the applicants, the Military ...
Biotech firm Promosome LLC sued Moderna (MRNA.O), Pfizer (PFE.N) and BioNTech (22UAy.DE), in federal court in San Diego, California, on Tuesday, accusing their COVID-19 vaccines of infringing a
property rights, experts believe Düsseldorf Regional Court will suspend the infringement proceedings in September. Although CureVac argues that BioNTech’s Covid19 vaccine Comirnaty infringes its IP
Circular No. 44 is to help individuals and businesses in Vietnam, which continue to struggle amid the challenges posed by the Covid-19 pandemic. Among these fees and charges are those for filing an
biopharma company HDT Bio to develop a COVID-19 vaccine. A sealed entry in the court's docket said that U.S. District Judge James Robart dismissed the case without prejudice, which means it can be
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
